182 related articles for article (PubMed ID: 6665765)
21. Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease.
Pan LC; Wilson DW; Segall HJ
Toxicology; 1993 Mar; 79(1):21-35. PubMed ID: 8475497
[TBL] [Abstract][Full Text] [Related]
22. The effect of immunosuppressants and adoptive transfer in monocrotaline pyrrole pneumotoxicity.
Bruner LH; Bull RW; Roth RA
Toxicol Appl Pharmacol; 1987 Oct; 91(1):1-12. PubMed ID: 3672514
[TBL] [Abstract][Full Text] [Related]
23. Complement is not involved in monocrotaline pyrrole-induced pulmonary injury.
Bruner LH; Johnson KJ; Till GO; Roth RA
Am J Physiol; 1988 Feb; 254(2 Pt 2):H258-64. PubMed ID: 3344816
[TBL] [Abstract][Full Text] [Related]
24. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole.
Reindel JF; Ganey PE; Wagner JG; Slocombe RF; Roth RA
Toxicol Appl Pharmacol; 1990 Nov; 106(2):179-200. PubMed ID: 2256110
[TBL] [Abstract][Full Text] [Related]
25. [Lung 3H-thymidine incorporation in monocrotaline (MCT)-treated rats--role of platelet-activating factor (PAF)].
Ono S; Tanita T; Ashino Y; Noda M; Tabata S; Hoshikawa Y; Ueda S; Nishimura T; Fujimura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 May; 32(5):441-5. PubMed ID: 8084100
[TBL] [Abstract][Full Text] [Related]
26. Effects of monocrotaline pretreatment of rats on removal of 5-hydroxytryptamine and noradrenaline by perfused lung.
Gillis CN; Huxtable RJ; Roth RA
Br J Pharmacol; 1978 Jul; 63(3):435-43. PubMed ID: 667487
[TBL] [Abstract][Full Text] [Related]
27. Monoamine and motor responses to cocaine are co-deficient in the Fawn-Hooded depressed animal model.
Broderick PA; Hope O
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):887-98. PubMed ID: 16626846
[TBL] [Abstract][Full Text] [Related]
28. Aggregation of platelets from monocrotaline pyrrole-treated rats.
Hilliker KS; Deyo JA; Bell TG; Roth RA
Thromb Res; 1983 Nov; 32(3):325-33. PubMed ID: 6419380
[TBL] [Abstract][Full Text] [Related]
29. Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
Hilliker KS; Roth RA
Br J Pharmacol; 1984 Jun; 82(2):375-80. PubMed ID: 6234044
[TBL] [Abstract][Full Text] [Related]
30. Thromboxane does not mediate pulmonary vascular response to monocrotaline pyrrole.
Ganey PE; Roth RA
Am J Physiol; 1987 Apr; 252(4 Pt 2):H743-8. PubMed ID: 2952022
[TBL] [Abstract][Full Text] [Related]
31. Cellular fibronectin and von Willebrand factor concentrations in plasma of rats treated with monocrotaline pyrrole.
Schultze AE; Emeis JJ; Roth RA
Biochem Pharmacol; 1996 Jan; 51(2):187-91. PubMed ID: 8615888
[TBL] [Abstract][Full Text] [Related]
32. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin synthesis in aorta and platelets of fawn-hooded rats with platelet storage pool disease and its response to cholesterol feeding.
Wey H; Gallon L; Subbiah MT
Thromb Haemost; 1982 Aug; 48(1):94-7. PubMed ID: 6890244
[TBL] [Abstract][Full Text] [Related]
34. [Mast cell hyperplasia in monocrotaline-induced pulmonary changes in rats].
Kuriyama T; Sawada A; Sugita T; Watanabe S; Shen SY; Hiroshima K; Hayashi Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Aug; 23(8):865-72. PubMed ID: 3935842
[No Abstract] [Full Text] [Related]
35. Effects of monocrotaline pyrrole on cultured rat pulmonary endothelium.
Hoorn CM; Wagner JG; Roth RA
Toxicol Appl Pharmacol; 1993 Jun; 120(2):281-7. PubMed ID: 8511798
[TBL] [Abstract][Full Text] [Related]
36. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
[TBL] [Abstract][Full Text] [Related]
37. Removal of 5-hydroxytryptamine by rat lungs.
Osim EE; Wyllie JH
Acta Physiol Hung; 1991; 78(2):181-9. PubMed ID: 1808984
[TBL] [Abstract][Full Text] [Related]
38. Procoagulant and fibrinolytic properties of bovine endothelial cells treated with monocrotaline pyrrole.
Schultze AE; Roth RA
Toxicol Appl Pharmacol; 1993 Sep; 122(1):7-15. PubMed ID: 8378934
[TBL] [Abstract][Full Text] [Related]
39. Early indications of monocrotaline pyrrole-induced lung injury in rats.
Schultze AE; Wagner JG; White SM; Roth RA
Toxicol Appl Pharmacol; 1991 Jun; 109(1):41-50. PubMed ID: 2038748
[TBL] [Abstract][Full Text] [Related]
40. The effect of dietary restriction and altered sodium intake on the cardiopulmonary toxicity of monocrotaline pyrrole.
Ganey PE; Fink GD; Roth RA
Toxicol Appl Pharmacol; 1985 Mar; 78(1):55-62. PubMed ID: 2930913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
